MARKET

SYNH

SYNH

SYNEOS HEALTH
NASDAQ

Real-time Quotes | Nasdaq Last Sale

62.51
-0.25
-0.40%
After Hours: 62.73 +0.22 +0.35% 16:00 08/11 EDT
OPEN
63.07
PREV CLOSE
62.76
HIGH
63.40
LOW
62.10
VOLUME
447.07K
TURNOVER
--
52 WEEK HIGH
74.25
52 WEEK LOW
30.02
MARKET CAP
6.51B
P/E (TTM)
35.12
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 14 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average SYNH stock price target is 72.31 with a high estimate of 83.00 and a low estimate of 61.00.

EPS

SYNH News

More
Syneos Health, Inc. (SYNH) CEO Alistair Macdonald on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 2d ago
Syneos Health EPS beats by $0.09, beats on revenue
Syneos Health (NASDAQ:SYNH): Q2 Non-GAAP EPS of $0.58 beats by $0.09; GAAP EPS of $0.04 beats by $0.05. Revenue of $1.01B (-13.7% Y/Y) beats by $10M. Press
seekingalpha · 5d ago
Syneos Health (SYNH) Q2 Earnings and Revenues Surpass Estimates
Syneos Health (SYNH) delivered earnings and revenue surprises of 20.83% and 0.92%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 5d ago
Syneos Health Reports Second Quarter 2020 Results
Highlights * GAAP revenue of $1,013.4 million for the three months ended June 30, 2020, representing a decline of 13.1%, 13.3% on an adjusted basis, and 12.8% on a constant currency adjusted basis compared to the same period in 2019. * Net new business awa
GlobeNewswire · 5d ago
Earnings Preview: Syneos Health (SYNH) Q2 Earnings Expected to Decline
Syneos Health (SYNH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/30 16:33
Did Hedge Funds Make The Right Call On Syneos Health, Inc. (SYNH) ?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional invest
Insider Monkey · 07/20 15:02
Syneos Health Signs New Service Agreement With Pfizer
MORRISVILLE, N.C., July 13, 2020 (GLOBE NEWSWIRE) -- Syneos Health® (NASDAQ:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it has signed a new three-year
Benzinga · 07/13 12:34
Syneos Health Signs New Service Agreement With Pfizer
MORRISVILLE, N.C., July 13, 2020 -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it has signed a new.
GlobeNewswire · 07/13 12:30

Industry

Biotechnology & Medical Research
-2.36%
Pharmaceuticals & Medical Research
-0.93%

Hot Stocks

Symbol
Price
%Change

About SYNH

Syneos Health Inc. is a fully integrated biopharmaceutical solutions providing company. The Company offers both stand-alone and integrated biopharmaceutical product development solutions through its Contract Research Organization (CRO) and Contract Commercial Organization (CCO), ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products. It brings together approximately 24,000 clinical and commercial professionals with the ability to support customers in more than 110 countries. Together it shares insights, leverages latest technologies and apply advanced business practices to deliver important therapies to patients.
More

Webull offers kinds of Syneos Health Inc stock information, including NASDAQ:SYNH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SYNH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SYNH stock methods without spending real money on the virtual paper trading platform.